The molecular mechanisms involved in the hypoxic generation of PGCCs, including HIF-1α stabilization, involvement of p53/p47 isoform and cell cycle arrest in G2, point to novel therapeutic targets for the prevention of tumor recurrence and treatment failure in colon cancer. Here, HIF1A is linked to neoplasm.